Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-006024
Filing Date
2012-02-02
Accepted
2012-02-02 08:35:18
Documents
10
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q a11-32244_110q.htm 10-Q 1546663
2 EX-31.1 a11-32244_1ex31d1.htm EX-31.1 20775
3 EX-31.2 a11-32244_1ex31d2.htm EX-31.2 20767
4 EX-32.1 a11-32244_1ex32d1.htm EX-32.1 8566
  Complete submission text file 0001104659-12-006024.txt   5541797

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT alks-20111231.xml EX-101.INS 829571
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alks-20111231.xsd EX-101.SCH 15735
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alks-20111231_cal.xml EX-101.CAL 55084
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alks-20111231_def.xml EX-101.DEF 99887
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT alks-20111231_lab.xml EX-101.LAB 281874
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alks-20111231_pre.xml EX-101.PRE 137758
Mailing Address TREASURY BUILDING LOWER GRAND CANAL STREET DUBLIN 2 L2 00000
Business Address TREASURY BUILDING LOWER GRAND CANAL STREET DUBLIN 2 L2 00000 00-353-1-649-2000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35299 | Film No.: 12564415
SIC: 2834 Pharmaceutical Preparations